Skip to content

Dr. F. Bakal

Active Private limited companyfounded 2019active for 6 yearsDrakenhoflaan 170, 2100 AntwerpKBO/BCE: BE 0738.907.396

Lifetime

7 annual accounts with figures on one time axis
peak of €86,358 in 2024
-€6,641▼ €93,000
lowest -€32,776 in 2025
-€32,776▼ €80,015
peak of €72,478 in 2024
€39,702▼ 45.2%
€450,230▼ 6.8%
Board1 name since 2019
1 director
Documentsfilings and deeds
24-08-202624 days late
2025micro format
Gross margin from €86,358 to -€6,641Loss of €32,776Equity from €72,478 to €39,702Cash from €32,624 to €52

Key points

from the 2025 annual accounts

Equity

€39,702 from €72,478 in 2024

Equity fell by 45% in 1 year.

Result

-€32,776 -€32,776
€47,2002024-€32,8002025

From profit to loss in 2025, after a profit of €47,238 in 2024.

Debts

€450,230 92% of the balance sheet
Financial debts 89%Suppliers 1%Taxes and wages 4%Other 5%

Of this, €47,880 falls due within a year.

Liquidity

0.95 was 1.64 in 2024

Short-term debts fell from €56,225 to €47,880.

Filings

7 annual accounts 4 late
AprilJune31 JulyOctober202020222024

The 2019 accounts came in latest, 31 days after the end of the period.

Position in the sector

-€32,776

Lower net result than 95% of companies in human health. Sector median €59,520 · 21,355 companies.

Turnover not published in the micro format

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 820 companies had the same profile as Dr. F. Bakal has now. Each dot stands for 3 companies, two years later.

94.6%
were still trading
3.2%
stopped another way
2.0%
went bankrupt
  • Small
  • 5 to 10 years old
  • solvency under 10%
  • a small loss

Another 0.2% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 820 companies, not a prediction for Dr. F. Bakal. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 10-12-2019
  • 200 sharesdeed of 12-12-2019
Board & ownership

Recent changes

New establishment in Antwerp BF Clinics, Frankrijklei 5
Incorporation Founding capital of €2,000, 200 shares · Founded by · appointed as director · published on 12-12-2019 · Gazette deed
First establishment BF Clinics, Drakenhoflaan 170, Antwerp
All 12 events

Comparable companies

same main activity, similar in size and age
Company
Dr. F. Bakal Antwerp €489,932 -€6,641 8.1% -
Pool de chirurgie viscérale Citadelle Chaudfontaine €464,456 -€18,293 -1.7% -
Dokter Marleen Dubin Hasselt €367,155 -€8,796 88.9% -
EbyK-ScopeConcept Uccle €754,210 -€96,853 99.4% -
Dr. I. Demeyer Aalst €418,660 -€71,180 64.0% -
OTLM Pepingen €587,882 -€61,699 93.9% -
DR. KETELS VEERLE - NEUROLOOG Lokeren €360,430 -€51,265 74.3% -

These companies have the same main activity as Dr. F. Bakal: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €360,000 and €754,000, founded between 2015 and 2022.

Official details

Source: KBO
Status
Active since 10-12-2019Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment units
2.296.628.7152100 Antwerp, since 10-12-2019
2.338.246.1682000 Antwerp, since 01-11-2022
Financial year end
31 December
Peppol
Reachable
Company details

Annual accounts 2025

€489,932▼ 11.8%
Filing
Filed on 24-08-2026
Financials

Insights on Dr. F. Bakal

Dr. F. Bakal files the micro format. That format states no turnover. The gross margin fell from €4,847 in 2019 to -€6,641 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. F. Bakal

What is the company number of Dr. F. Bakal?
The company number of Dr. F. Bakal is 0738.907.396. The VAT number is the same number with BE in front: BE 0738.907.396.
Where is Dr. F. Bakal based?
The registered office is at Drakenhoflaan 170, 2100 Antwerp.Company details
What does Dr. F. Bakal do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. F. Bakal?
Dr. F. Bakal is a private limited company (BV).
When was Dr. F. Bakal founded?
Dr. F. Bakal was founded on 10-12-2019.
Is Dr. F. Bakal still active?
Yes, Dr. F. Bakal is an active enterprise in the KBO register.
What is the turnover of Dr. F. Bakal?
The annual accounts for financial year 2025 state no turnover. The micro format does not require it.Financials
Is Dr. F. Bakal profitable?
In financial year 2025, Dr. F. Bakal made a loss of €32,776.
Where can I find the annual accounts of Dr. F. Bakal?
Dr. F. Bakal filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. F. Bakal due?
Dr. F. Bakal must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.